w66最给力的老牌生物科技（天津）有限公司
400-621-6806
周一至周六
8:00-18:00
服务电话：400-621-6806
地址：天津市武清区国际企业社区A5号楼四层，301700
邮箱：
| 产品编号 | KMP2348 |
|---|---|
| 产品名称 | Mouse CD276 Protein, His Tag |
| 产品描述 | The Mouse CD276 Protein(KMP2348) is produced in HEK293 Cells and the target gene encoding Val29-Phe244 is expressed with a 6His tag at the C-terminus. |
| 物种 | Mouse |
| 宿主 | HEK293 Cells |
| 规格 | 50ug, 100ug, 200ug |
| 纯化方式 | Affinity purification |
| 内毒素水平 | <1.0 EU/ug determined by the LAL method |
| 缓冲体系 | PBS, pH7.4 |
| SDS-PAGE |  |
| 功能 | Modulates T-cell-mediated immune responses and the development of acute and chronic transplant rejection. Plays a positive regulatory role in bone formation and has a dual role in the bone-immune interface. Induces antitumor immunity as it activates both acquired and innate immunity leading to natural killer cell and CD8 T-cell dependent killing of tumor cells. |
| 产品背景 | CD276, also known as B7-H3, is a member of the B7 superfamily with signature IgV and IgG regions in extracellular domains. It is a type I transmembrane protein and shares 20–27% amino acid identity with other B7 family members. B7-H3 is involved in the activation of T lymphocytes, and regulates murine bone formation. It is also reported that B7-H3 may play an important role in muscle-immune interactions, providing further evidence of the active role of muscle cells in local immunoregulatory processes. B7-H3 is expressed on T-cells, natural killer cells, and antigen presenting cells, as well as some non-immune cells, such as osteoblasts, fibroblasts, fibroblast-like synoviocytes and epithelial cells. High expression of B7-H3 in tumor vasculature also correlates with poor survival in patients, suggesting that it may play a role in tumor cell migration. |
| 保存条件 | Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles. |
| 说明 | This product is for research use only. |
| 参考文献 | 1.J. Immunol. 168:6294-6297 (2002) 2.Nat. Immunol. 4:899-906 (2003) 3.Gene Ther. 10:1728-1734 (2003) 4.J. Immunol. 173:2500-2506 (2004) 5.Eur. J. Immunol. 35:428-438 (2005) |
